{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T17:30:09Z","timestamp":1788629409001,"version":"build-2803163510"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T00:00:00Z","timestamp":1600992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T00:00:00Z","timestamp":1600992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","award":["#AID-OAA-A-11-00051"],"award-info":[{"award-number":["#AID-OAA-A-11-00051"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009130","name":"Programme Development Grants","doi-asserted-by":"publisher","award":["Health Protection Research Unit in Evaluation of Interventions"],"award-info":[{"award-number":["Health Protection Research Unit in Evaluation of Interventions"]}],"id":[{"id":"10.13039\/501100009130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1084416"],"award-info":[{"award-number":["OPP1084416"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>In sub-Saharan Africa, considerable HIV-burden exists among women. Anti-retroviral (ARV) based prevention products could decrease this burden, and their uptake could be increased if they also protect against pregnancy and sexually transmitted infections (STI).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A discrete choice experiment (DCE) was undertaken in South Africa (2015) through a household survey of adult females (<jats:italic>n<\/jats:italic>\u2009=\u2009158) and adolescent girls (<jats:italic>n<\/jats:italic>\u2009=\u2009204) who self-reported HIV-negative status. The DCE was used to project the uptake (percentage using product) of oral pre-exposure prophylaxis (PrEP), vaginal rings, and injectable long-lasting ARV agents among these women, and how uptake could depend on whether these products protect against pregnancy or STI acquisition. Uptake estimates were used to model how each product could decrease a women\u2019s HIV acquisition risk.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In adolescent women, there will be limited uptake (&lt;\u20096% for any product) and impact (&lt;\u20094% decrease in HIV acquisition risk) of new products unless they provide pregnancy protection, which could quadruple use and impact. Adult women have weaker preference for pregnancy protection, with moderate use (&lt;\u200917% for each) and impact (&lt;\u200914 percentage point decrease) if they only provide HIV protection. All women had highest preference for injectable ARVs, with oral PrEP having high preference if injectable ARVs are not available. Adult women will use the ring, but adolescent women will not. Importantly, even with three additional prevention products, all providing pregnancy and STI protection, &gt;\u200914% of women will remain unprotected and\u2009&gt;\u200931% of the baseline acquisition risk will remain.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Incorporating multiple prevention components into new ARV-based prevention products may increase their uptake and impact among women.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-020-05399-4","type":"journal-article","created":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T11:03:08Z","timestamp":1601031788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["HIV prevention is not all about HIV \u2013 using a discrete choice experiment among women to model how the uptake and effectiveness of HIV prevention products may also rely on pregnancy and STI protection"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8291-5890","authenticated-orcid":false,"given":"Peter","family":"Vickerman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Quaife","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie","family":"Kilbourne-Brook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercy","family":"Mvundura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn","family":"Eakle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fern","family":"Terris-Prestholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,25]]},"reference":[{"key":"5399_CR1","volume-title":"World AIDS day report - fact sheet 2014","author":"UNAIDS","year":"2014","unstructured":"UNAIDS. World AIDS day report - fact sheet 2014. Geneva: UNAIDS; 2014."},{"key":"5399_CR2","volume-title":"We\u2019ve got the power - Women, Adolescent girls and the HIV response","author":"UNAIDS","year":"2020","unstructured":"UNAIDS. We\u2019ve got the power - Women, Adolescent girls and the HIV response. 2020."},{"issue":"4","key":"5399_CR3","first-page":"34","volume":"18","author":"A Peters","year":"2014","unstructured":"Peters A, Van Driel F, Jansen W. Acceptability of the female condom by sub-Saharan African women: a literature review. Afr J Reprod Health. 2014;18(4):34\u201344.","journal-title":"Afr J Reprod Health"},{"issue":"35","key":"5399_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0968-8080(10)35499-1","volume":"18","author":"A Peters","year":"2010","unstructured":"Peters A, Jansen W, Van Driel F. The female condom: the international denial of a strong potential. Reprod Health Matters. 2010;18(35):119\u201328.","journal-title":"Reprod Health Matters"},{"key":"5399_CR5","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1097\/01.aids.0000341774.86500.53","volume":"22","author":"S Leclerc-Madlala","year":"2008","unstructured":"Leclerc-Madlala S. Age-disparate and intergenerational sex in southern Africa: the dynamics of hypervulnerability. Aids. 2008;22:S17\u201325.","journal-title":"Aids."},{"issue":"3","key":"5399_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1071\/SH06070","volume":"4","author":"J Nkosana","year":"2007","unstructured":"Nkosana J, Rosenthal D. The dynamics of intergenerational sexual relationships: the experience of schoolgirls in Botswana. Sex Health. 2007;4(3):181\u20137.","journal-title":"Sex Health"},{"issue":"6","key":"5399_CR7","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa1105243","volume":"365","author":"MS Cohen","year":"2011","unstructured":"Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493\u2013505.","journal-title":"N Engl J Med"},{"key":"5399_CR8","doi-asserted-by":"crossref","unstructured":"Fatti G, Mothibi E, Shaikh N, Grimwood A. Improved long-term antiretroviral treatment outcomes amongst patients receiving community-based adherence support in South Africa. AIDS Care. 2016:1\u20138.","DOI":"10.1016\/S2055-6640(20)31177-8"},{"issue":"9","key":"5399_CR9","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/cid\/civ556","volume":"61","author":"TS Boender","year":"2015","unstructured":"Boender TS, Sigaloff KC, McMahon JH, Kiertiburanakul S, Jordan MR, Barcarolo J, et al. Long-term virological outcomes of first-line antiretroviral therapy for HIV-1 in low-and middle-income countries: a systematic review and meta-analysis. Clin Infect Dis. 2015;61(9):1453\u201361.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"5399_CR10","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/QAI.0000000000001160","volume":"73","author":"B Hanscom","year":"2016","unstructured":"Hanscom B, Janes HE, Guarino PD, Huang Y, Brown ER, Chen YQ, et al. Preventing HIV-1 Infection in Women using Oral Pre-Exposure Prophylaxis: A Meta-analysis of Current Evidence. J Acquir Immune Defic Syndr (1999). 2016;73(5):606\u20138.","journal-title":"J Acquir Immune Defic Syndr (1999)"},{"issue":"3","key":"5399_CR11","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/QAI.0000000000000158","volume":"66","author":"AL Corneli","year":"2014","unstructured":"Corneli AL, Deese J, Wang M, Taylor D, Ahmed K, Agot K, et al. FEM-PrEP: adherence patterns and factors associated with adherence to a daily oral study product for pre-exposure prophylaxis. JAIDS J Acquir Immune Defic Syndr. 2014;66(3):324\u201331.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"6","key":"5399_CR12","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa1402269","volume":"372","author":"JM Marrazzo","year":"2015","unstructured":"Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015;372(6):509\u201318.","journal-title":"N Engl J Med"},{"key":"5399_CR13","doi-asserted-by":"publisher","first-page":"e25298","DOI":"10.1002\/jia2.25298","volume":"22","author":"CL Celum","year":"2019","unstructured":"Celum CL, Delany-Moretlwe S, Baeten JM, van der Straten A, Hosek S, Bukusi EA, et al. HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery. J Int AIDS Soc. 2019;22:e25298.","journal-title":"J Int AIDS Soc"},{"key":"5399_CR14","doi-asserted-by":"crossref","unstructured":"Mack N, Evens E, Tolley E, Brelsford K, McKenzie C, Milford C. The importance of choice in the rollout of ARV-based prevention to user groups in Kenya and South Africa: a qualitative study. J Int AIDS Soc. 2014;17(s2).","DOI":"10.7448\/IAS.17.3.19157"},{"issue":"3","key":"5399_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.contraception.2009.11.009","volume":"81","author":"BY Holt","year":"2010","unstructured":"Holt BY, Kilbourne-Brook M, Stone A, Harrison P, Shields WC. Multipurpose prevention technologies for sexual and reproductive health: gaining momentum and promise. Contraception. 2010;81(3):177\u201380.","journal-title":"Contraception."},{"issue":"9962","key":"5399_CR16","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S0140-6736(14)60974-0","volume":"385","author":"L-G Bekker","year":"2015","unstructured":"Bekker L-G, Johnson L, Cowan F, Overs C, Besada D, Hillier S, et al. Combination HIV prevention for female sex workers: what is the evidence? Lancet. 2015;385(9962):72\u201387.","journal-title":"Lancet"},{"issue":"4","key":"5399_CR17","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/COH.0000000000000169","volume":"10","author":"DA Margolis","year":"2015","unstructured":"Margolis DA, Boffito M. Long-acting antiviral agents for HIV treatment. Curr Opin HIV AIDS. 2015;10(4):246\u201352.","journal-title":"Curr Opin HIV AIDS"},{"key":"5399_CR18","unstructured":"Buchbinder SP, Liu AY. CROI 2016: Hot spots in HIV infection and advances in HIV prevention."},{"issue":"22","key":"5399_CR19","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","volume":"375","author":"JM Baeten","year":"2016","unstructured":"Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V, et al. Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. N Engl J Med. 2016;375(22):2121\u201332.","journal-title":"N Engl J Med"},{"issue":"11","key":"5399_CR20","doi-asserted-by":"publisher","first-page":"e1002690","DOI":"10.1371\/journal.pmed.1002690","volume":"15","author":"RJ Landovitz","year":"2018","unstructured":"Landovitz RJ, Li S, Grinsztejn B, Dawood H, Liu AY, Magnus M, et al. Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial. PLoS Med. 2018;15(11):e1002690.","journal-title":"PLoS Med"},{"key":"5399_CR21","volume-title":"A phase III trial of the Dapivirine vaginal ring for HIV-1 prevention in women","author":"JM Baeten","year":"2016","unstructured":"Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Nel A, et al. A phase III trial of the Dapivirine vaginal ring for HIV-1 prevention in women. Boston: Conference on Retroviruses and Opportunistic Infections; 2016."},{"key":"5399_CR22","volume-title":"Safety and Efficacy of Dapivirine Vaginal Ring for HIV-1 Prevention in African Women","author":"A Nel","year":"2016","unstructured":"Nel A, Kapiga S, Bekker L-G, Devlin B, Borremans M, Rosenberg Z, et al. Safety and Efficacy of Dapivirine Vaginal Ring for HIV-1 Prevention in African Women. Seattle: CROI 2016; 2016."},{"key":"5399_CR23","volume-title":"High uptake and reduced HIV-1 incidence in an open-label trial of the dapivirine ring. 25th Conference on Retroviruses and Opportunistic Infections (CROI)","author":"J Baeten","year":"2018","unstructured":"Baeten J, Palanee-Phillips T, Mgodi N, Mayo A, Nel A, Rosenberg Z, et al.. High uptake and reduced HIV-1 incidence in an open-label trial of the dapivirine ring. 25th Conference on Retroviruses and Opportunistic Infections (CROI); 2018."},{"key":"5399_CR24","volume-title":"Long-Acting Injectable Drug Prevents HIV Among Men Who Have Sex with Men and Transgender Women","author":"National Institute of Health","year":"2020","unstructured":"National Institute of Health. Long-Acting Injectable Drug Prevents HIV Among Men Who Have Sex with Men and Transgender Women 2020 [Available from: https:\/\/www.niaid.nih.gov\/news-events\/long-acting-injectable-drug-prevents-hiv-among-men-who-have-sex-men-and-transgender)."},{"issue":"7","key":"5399_CR25","doi-asserted-by":"publisher","first-page":"e289","DOI":"10.1016\/S2352-3018(16)30036-4","volume":"3","author":"JA Smith","year":"2016","unstructured":"Smith JA, Anderson S-J, Harris KL, McGillen JB, Lee E, Garnett GP, et al. Maximising HIV prevention by balancing the opportunities of today with the promises of tomorrow: a modelling study. Lancet HIV. 2016;3(7):e289\u2013e96.","journal-title":"Lancet HIV"},{"issue":"3","key":"5399_CR26","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/QAD.0b013e32835ca2dd","volume":"27","author":"I Cremin","year":"2013","unstructured":"Cremin I, Alsallaq R, Dybul M, Piot P, Garnett G, Hallett TB. The new role of antiretrovirals in combination HIV prevention: a mathematical modelling analysis. Aids. 2013;27(3):447\u201358.","journal-title":"Aids."},{"issue":"15","key":"5399_CR27","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1097\/QAD.0000000000000798","volume":"29","author":"KM Mitchell","year":"2015","unstructured":"Mitchell KM, L\u00e9pine A, Terris-Prestholt F, Torpey K, Khamofu H, Folayan MO, et al. Modelling the impact and cost-effectiveness of combination prevention amongst HIV serodiscordant couples in Nigeria. AIDS (London, England). 2015;29(15):2035.","journal-title":"AIDS (London, England)"},{"issue":"1","key":"5399_CR28","doi-asserted-by":"publisher","first-page":"20942","DOI":"10.7448\/IAS.19.1.20942","volume":"19","author":"KM Mitchell","year":"2016","unstructured":"Mitchell KM, Prudden HJ, Washington R, Isac S, Rajaram SP, Foss AM, et al. Potential impact of pre-exposure prophylaxis for female sex workers and men who have sex with men in Bangalore, India: a mathematical modelling study. J Int AIDS Soc. 2016;19(1):20942.","journal-title":"J Int AIDS Soc"},{"issue":"4","key":"5399_CR29","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1517\/17425247.2016.1134485","volume":"13","author":"DR Friend","year":"2016","unstructured":"Friend DR. An update on multipurpose prevention technologies for the prevention of HIV transmission and pregnancy. Expert Opin Drug Deliv. 2016;13(4):533\u201345.","journal-title":"Expert Opin Drug Deliv"},{"key":"5399_CR30","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/hec.3297","volume":"25","author":"F Terris-Prestholt","year":"2016","unstructured":"Terris-Prestholt F, Quaife M, Vickerman P. Parameterising user uptake in economic evaluations: the role of discrete choice experiments. Health Econ. 2016;25:116\u201323.","journal-title":"Health Econ"},{"key":"5399_CR31","volume-title":"Frontiers in econometrics","author":"D McFadden","year":"1974","unstructured":"McFadden D. Conditional logit analysis of qualitative choice behaviour. In: Zarembka P, editor. Frontiers in econometrics. New York: Academic Press; 1974."},{"key":"5399_CR32","doi-asserted-by":"crossref","unstructured":"McFadden DL. Chapter 24 Econometric analysis of qualitative response models. In: Zvi G, Michael DI, editors. Handbook of Econometrics, vol. 2: Elsevier; 1984. p. 1395\u2013457.","DOI":"10.1016\/S1573-4412(84)02016-X"},{"key":"5399_CR33","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9781316136232","volume-title":"Applied choice analysis: second edition","author":"D Hensher","year":"2015","unstructured":"Hensher D, Rose J, Greene W. Applied choice analysis: second edition. Cambridge: Cambridge University Press; 2015."},{"issue":"2","key":"5399_CR34","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/hec.1697","volume":"21","author":"EW de Bekker-Grob","year":"2012","unstructured":"de Bekker-Grob EW, Ryan M, Gerard K. Discrete choice experiments in health economics: a review of the literature. Health Econ. 2012;21(2):145\u201372.","journal-title":"Health Econ"},{"issue":"8","key":"5399_CR35","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/j.ecolecon.2010.04.011","volume":"69","author":"D Hoyos","year":"2010","unstructured":"Hoyos D. The state of the art of environmental valuation with discrete choice experiments. Ecol Econ. 2010;69(8):1595\u2013603.","journal-title":"Ecol Econ"},{"key":"5399_CR36","doi-asserted-by":"crossref","unstructured":"Quaife M, Terris-Prestholt F, Eakle R, Cabrera M, Kilbourne-Brook M, Mvundura M, et al. The cost-effectiveness of multipurpose HIV and pregnancy prevention technologies in South Africa. J Int AIDS Soc. 2018.","DOI":"10.1002\/jia2.25064"},{"key":"5399_CR37","doi-asserted-by":"crossref","unstructured":"Hughes JP, Baeten JM, Lingappa JR, Magaret AS, Wald A, de Bruyn G, et al. Determinants of per-coital-act HIV-1 infectivity among African HIV-1\u2013serodiscordant couples. J Infect Dis. 2012:jir747.","DOI":"10.1016\/j.yobg.2012.06.180"},{"key":"5399_CR38","first-page":"1","volume":"4","author":"S Weller","year":"2007","unstructured":"Weller S, Davis-Beaty K. Condom effectiveness in reducing heterosexual HIV transmission (review). Cochrane Libr. 2007;4:1\u201324.","journal-title":"Cochrane Libr"},{"key":"5399_CR39","volume-title":"The Future of ARV-Based Prevention and More","author":"AVAC","year":"2019","unstructured":"AVAC. The Future of ARV-Based Prevention and More 2019 [Available from: https:\/\/www.avac.org\/infographic\/future-arv-based-prevention."},{"issue":"6","key":"5399_CR40","doi-asserted-by":"publisher","first-page":"e010682","DOI":"10.1136\/bmjopen-2015-010682","volume":"6","author":"M Quaife","year":"2016","unstructured":"Quaife M, Eakle R, Cabrera M, Vickerman P, Tsepe M, Cianci F, et al. Preferences for ARV-based HIV prevention methods among men and women, adolescent girls and female sex workers in Gauteng Province, South Africa: a protocol for a discrete choice experiment. BMJ Open. 2016;6(6):e010682.","journal-title":"BMJ Open"},{"key":"5399_CR41","doi-asserted-by":"crossref","unstructured":"Quaife M, Eakle R, Cabrera Escobar MA, Vickerman P, Kilbourne-Brook M, Mvundura M, et al. Divergent Preferences for HIV Prevention: A Discrete Choice Experiment for Multipurpose HIV Prevention Products in South Africa. Med Decis Mak. 2017:0272989X17729376.","DOI":"10.1177\/0272989X17729376"},{"key":"5399_CR42","volume-title":"South African census 2011","author":"SA STATS","year":"2011","unstructured":"STATS SA. South African census 2011; 2011."},{"key":"5399_CR43","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511610356","volume-title":"Applied choice analysis: a primer","author":"D Henscher","year":"2005","unstructured":"Henscher D, Rose J, Greene W. Applied choice analysis: a primer. Cambridge: Cambridge University Press; 2005."},{"key":"5399_CR44","first-page":"284","volume-title":"Predicting the place of out-of-hours care-A market simulation based on discrete choice analysis Ireland: Elsevier Ireland Ltd (P.O. Box 85, Limerick, Ireland)","author":"H Philips","year":"2012","unstructured":"Philips H, Mahr D, Remmen R, Weverbergh M, De Graeve D, Van Royen P. Predicting the place of out-of-hours care-A market simulation based on discrete choice analysis Ireland: Elsevier Ireland Ltd (P.O. Box 85, Limerick, Ireland), vol. 3; 2012. p. 284\u201390. Available from: http:\/\/ovidsp.ovid.com\/ovidweb.cgi?T=JS&PAGE=reference&D=emed10&NEWS=N&AN=2012407174."},{"key":"5399_CR45","doi-asserted-by":"crossref","unstructured":"Quaife M, Terris-Prestholt F, Di Tanna GL, Vickerman P. How well do discrete choice experiments predict health choices? A systematic review and meta-analysis of external validity. Eur J Health Econ. 2018.","DOI":"10.1007\/s10198-018-0954-6"},{"issue":"1","key":"5399_CR46","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2989\/16085906.2016.1153491","volume":"15","author":"K Zuma","year":"2016","unstructured":"Zuma K, Shisana O, Rehle TM, Simbayi LC, Jooste S, Zungu N, et al. New insights into HIV epidemic in South Africa: key findings from the national HIV prevalence, incidence and behaviour survey, 2012. Afr J AIDS Res. 2016;15(1):67\u201375.","journal-title":"Afr J AIDS Res"},{"key":"5399_CR47","volume-title":"South African national HIV prevalence, Incidence, Behaviour and Communication Survey, 2017","author":"L Simbayi","year":"2018","unstructured":"Simbayi L, Zuma K, Moyo S, Marinda E, Mabaso M, Ramlagan S, et al. South African national HIV prevalence, Incidence, Behaviour and Communication Survey, 2017. 2018."},{"issue":"1","key":"5399_CR48","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s13643-017-0650-0","volume":"6","author":"C-B Sama","year":"2017","unstructured":"Sama C-B, Ngasa SN, Dzekem BS, Choukem S-P. Prevalence, predictors and adverse outcomes of adolescent pregnancy in sub-Saharan Africa: a protocol of a systematic review. Syst Rev. 2017;6(1):247.","journal-title":"Syst Rev"},{"issue":"3","key":"5399_CR49","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/COH.0000000000000453","volume":"13","author":"A Pettifor","year":"2018","unstructured":"Pettifor A, Stoner M, Pike C, Bekker L-G. Adolescent lives matter: preventing HIV in adolescents. Curr Opin HIV AIDS. 2018;13(3):265.","journal-title":"Curr Opin HIV AIDS"},{"key":"5399_CR50","volume-title":"90\u201390-90: an ambitious treatment target to help end the AIDS epidemic","author":"HIV\/AIDS JUNPo, HIV\/Aids JUNPo","year":"2014","unstructured":"HIV\/AIDS JUNPo, HIV\/Aids JUNPo. 90\u201390-90: an ambitious treatment target to help end the AIDS epidemic. Geneva: UNAIDS; 2014."},{"issue":"6","key":"5399_CR51","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.jadohealth.2011.02.012","volume":"49","author":"SN Mavedzenge","year":"2011","unstructured":"Mavedzenge SN, Olson R, Doyle AM, Changalucha J, Ross DA. The epidemiology of HIV among young people in sub-Saharan Africa: know your local epidemic and its implications for prevention. J Adolesc Health. 2011;49(6):559\u201367.","journal-title":"J Adolesc Health"},{"key":"5399_CR52","doi-asserted-by":"crossref","unstructured":"Celum CL, Delany-Moretlwe S, McConnell M, Van Rooyen H, Bekker L-G, Kurth A, et al. Rethinking HIV prevention to prepare for oral PrEP implementation for young African women. J Int AIDS Soc. 2015;18(4).","DOI":"10.7448\/IAS.18.4.20227"},{"issue":"7","key":"5399_CR53","doi-asserted-by":"publisher","first-page":"F13","DOI":"10.1097\/QAD.0b013e3283522272","volume":"26","author":"A van der Straten","year":"2012","unstructured":"van der Straten A, Van Damme L, Haberer JE, Bangsberg DR. Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention. Aids. 2012;26(7):F13\u2013F9.","journal-title":"Aids."},{"issue":"7","key":"5399_CR54","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.tim.2015.02.006","volume":"23","author":"JA Fernandez-Romero","year":"2015","unstructured":"Fernandez-Romero JA, Deal C, Herold BC, Schiller J, Patton D, Zydowsky T, et al. Multipurpose prevention technologies: the future of HIV and STI protection. Trends Microbiol. 2015;23(7):429\u201336.","journal-title":"Trends Microbiol"},{"key":"5399_CR55","doi-asserted-by":"crossref","unstructured":"Minnis AM, Roberts ST, Agot K, Weinrib R, Ahmed K, Manenzhe K, et al. Young Women\u2019s ratings of three placebo multipurpose prevention technologies for HIV and pregnancy prevention in a randomized, cross-over study in Kenya and South Africa. AIDS Behav. 2018:1\u201312.","DOI":"10.1007\/s10461-018-2078-5"},{"issue":"1","key":"5399_CR56","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10461-017-1911-6","volume":"22","author":"R Weinrib","year":"2018","unstructured":"Weinrib R, Minnis A, Agot K, Ahmed K, Owino F, Manenzhe K, et al. End-users\u2019 product preference across three multipurpose prevention technology delivery forms: baseline results from young women in Kenya and South Africa. AIDS Behav. 2018;22(1):133\u201345.","journal-title":"AIDS Behav"},{"issue":"1","key":"5399_CR57","doi-asserted-by":"publisher","first-page":"e28238","DOI":"10.1371\/journal.pone.0028238","volume":"7","author":"AB Eisingerich","year":"2012","unstructured":"Eisingerich AB, Wheelock A, Gomez GB, Garnett GP, Dybul MR, Piot PK. Attitudes and acceptance of Oral and parenteral HIV Preexposure prophylaxis among potential user groups: a multinational study. PLoS One. 2012;7(1):e28238.","journal-title":"PLoS One"},{"issue":"2","key":"5399_CR58","doi-asserted-by":"publisher","first-page":"e25081","DOI":"10.1002\/jia2.25081","volume":"21","author":"R Eakle","year":"2018","unstructured":"Eakle R, Bourne A, Mbogua J, Mutanha N, Rees H. Exploring acceptability of oral PrEP prior to implementation among female sex workers in South Africa. J Int AIDS Soc. 2018;21(2):e25081.","journal-title":"J Int AIDS Soc"},{"issue":"11","key":"5399_CR59","doi-asserted-by":"publisher","first-page":"e1002444","DOI":"10.1371\/journal.pmed.1002444","volume":"14","author":"R Eakle","year":"2017","unstructured":"Eakle R, Gomez GB, Naicker N, Bothma R, Mbogua J, Cabrera Escobar MA, et al. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: results from a prospective observational demonstration project. PLoS Med. 2017;14(11):e1002444.","journal-title":"PLoS Med"},{"key":"5399_CR60","unstructured":"Ahmed K, Baeten JM, Beksinska M, Bekker L-G, Bukusi EA, Donnell D, et al. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial. Lancet. 2019."},{"key":"5399_CR61","doi-asserted-by":"crossref","unstructured":"Badawi MM, SalahEldin MA, Idris AB, Hasabo EA, Osman ZH, Osman WM. Knowledge gaps of STIs in Africa; Systematic review. PLoS One. 2019;14(9).","DOI":"10.1371\/journal.pone.0213224"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05399-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05399-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05399-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T23:10:05Z","timestamp":1632525005000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05399-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,25]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5399"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05399-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,25]]},"assertion":[{"value":"16 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the University of the Witwatersrand Human Research Ethics Committee and the Research Ethics Committee at the London School of Hygiene and Tropical Medicine. All participation in the Discrete Choice Experiment, alongside supporting qualitative studies, was voluntary and subject to completion of written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"704"}}